Mrs. Chelsy Ann Boelkins is a Cadillac, Michigan based nurse practitioner. Active license number of Mrs. Chelsy Ann Boelkins is 4704333746 in Michigan. Her current practice location is 9065 34 Rd, Cadillac. Patients can reach her at 231-577-5017. Mrs. Chelsy Ann Boelkins is MSN, FNP-C and her NPI number (Unique professional ID assigned by NPPES) is 1437868924. Mrs. Chelsy Ann Boelkins has completed additional training beyond basic nursing education and provides primary health care services in accordance with state nurse practice laws or statutes. NPs are trained to assess patient needs, order and interpret diagnostic and laboratory tests, diagnose disease, formulate and prescribe medications and treatment plans.
Complete Profile:
Mrs. Chelsy Ann Boelkins speciality, credentials, practice address, contact phone number and fax are as below.
Patients can call on the below given phone number for appointment.
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
NPI Number:
1437868924
NPI Enumeration Date:
23 Nov, 2022
NPI Last Update On:
30 Jun, 2023
Medical Licenses:
NPs can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Mrs. Chelsy Ann Boelkins are as mentioned below.
License Number
Specialization
State
Status
4704333746
Michigan
Primary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
Mrs. Chelsy Ann Boelkins 6515 Center Rd, Traverse City, Michigan
Zip:
49686-1877
Phone Number:
616-340-5008
Patients can reach Mrs. Chelsy Ann Boelkins at 9065 34 Rd, Cadillac, Michigan or can call to book an appointment on 231-577-5017.
Comments/ Reviews:
Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 13 January, 2025.